Bagyawantha N M Y, Coombes I D, Gawarammana I, Mohamed F
Department of Pharmacy, Faculty of Allied Health Sciences, University of Peradeniya, Peradeniya, Sri Lanka.
South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
J Pharm Policy Pract. 2025 Mar 3;18(1):2468782. doi: 10.1080/20523211.2025.2468782. eCollection 2025.
Acute coronary syndrome is a major global disease burden with high morbidity and mortality. This study aims to assess the impact of clinical pharmacy interventions on improving the quality use of medicines and drug-related problems in acute coronary syndrome patients.
An open, prospective, controlled, nonrandomised clinical trial was conducted at the Teaching Hospital, Peradeniya, Sri Lanka. Consenting patients were recruited and divided into control and intervention groups. Medication history, medication adherence and drug-related problems were assessed. The intervention group received clinical pharmacy interventions for six months. Improvements in medication adherence, discharge medication appropriateness, reduction of hospital readmissions for six months, and responses from the healthcare team's awareness and perception on clinical pharmacy services were recorded.
Both groups (control - 180 patients, intervention - 185 patients) showed poor medication adherence at baseline. Medication adherence improved significantly after 6-months post-discharge in the intervention group compared to the control group (49.3% vs 18.8%). The clinical pharmacists successfully identified drug-related problems and provided suggestions for resolving them. The treating team accepted the majority (60%) of these suggestions. Discharge medication appropriateness in the intervention group was significantly higher compared to the control group. There was no significant difference in hospital readmissions related to cardiovascular disorders between the groups. Most doctors and nurses were aware of clinical pharmacists but none of them had previously worked with one.
Clinical pharmacist-led interventions significantly improved medication adherence and appropriateness, underscoring the added value of clinical pharmacists in a multidisciplinary healthcare team. While most doctors and nurses were aware of clinical pharmacists, none of them had prior experience working with them, emphasising an opportunity to foster greater multidisciplinary integration for improved health outcomes. Overall findings highlight the potential role of clinical pharmacists in enhancing good patient outcomes and improving real-world patient care.
急性冠状动脉综合征是一种全球主要的疾病负担,发病率和死亡率都很高。本研究旨在评估临床药学干预对改善急性冠状动脉综合征患者合理用药及药物相关问题的影响。
在斯里兰卡佩拉德尼亚教学医院进行了一项开放、前瞻性、对照、非随机临床试验。招募了同意参与的患者并将其分为对照组和干预组。评估了用药史、用药依从性和药物相关问题。干预组接受了为期六个月的临床药学干预。记录了用药依从性的改善情况、出院用药的合理性、六个月内医院再入院率的降低情况,以及医疗团队对临床药学服务的认知和看法。
两组(对照组180例患者,干预组185例患者)在基线时用药依从性均较差。与对照组相比,干预组出院后6个月用药依从性显著提高(49.3%对18.8%)。临床药师成功识别出药物相关问题并提供了解决建议。治疗团队接受了大部分(60%)这些建议。干预组出院用药合理性显著高于对照组。两组之间与心血管疾病相关的医院再入院率无显著差异。大多数医生和护士都知道临床药师,但他们之前都没有与临床药师合作过。
临床药师主导的干预显著提高了用药依从性和合理性,凸显了临床药师在多学科医疗团队中的附加价值。虽然大多数医生和护士都知道临床药师,但他们之前都没有与临床药师合作的经验,这强调了有机会促进更大程度的多学科整合以改善健康结局。总体研究结果突出了临床药师在提高患者良好结局和改善实际患者护理方面的潜在作用。